Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1233254.RAE3k7yYND35Hf8Y8YzhFUMt8Aks3Xbc2sDD0Tu02wrHc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1233254.RAE3k7yYND35Hf8Y8YzhFUMt8Aks3Xbc2sDD0Tu02wrHc130_assertion type Assertion NP1233254.RAE3k7yYND35Hf8Y8YzhFUMt8Aks3Xbc2sDD0Tu02wrHc130_head.
- NP1233254.RAE3k7yYND35Hf8Y8YzhFUMt8Aks3Xbc2sDD0Tu02wrHc130_assertion description "[The present results indicated that LY294002 inhibits the malignant phenotype of OS cells via modulation of the PI3K/Akt/FASN signaling pathway in vitro and may be a new therapeutic strategy for the management of OS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233254.RAE3k7yYND35Hf8Y8YzhFUMt8Aks3Xbc2sDD0Tu02wrHc130_provenance.
- NP1233254.RAE3k7yYND35Hf8Y8YzhFUMt8Aks3Xbc2sDD0Tu02wrHc130_assertion evidence source_evidence_literature NP1233254.RAE3k7yYND35Hf8Y8YzhFUMt8Aks3Xbc2sDD0Tu02wrHc130_provenance.
- NP1233254.RAE3k7yYND35Hf8Y8YzhFUMt8Aks3Xbc2sDD0Tu02wrHc130_assertion SIO_000772 25351625 NP1233254.RAE3k7yYND35Hf8Y8YzhFUMt8Aks3Xbc2sDD0Tu02wrHc130_provenance.
- NP1233254.RAE3k7yYND35Hf8Y8YzhFUMt8Aks3Xbc2sDD0Tu02wrHc130_assertion wasDerivedFrom befree-2016 NP1233254.RAE3k7yYND35Hf8Y8YzhFUMt8Aks3Xbc2sDD0Tu02wrHc130_provenance.
- NP1233254.RAE3k7yYND35Hf8Y8YzhFUMt8Aks3Xbc2sDD0Tu02wrHc130_assertion wasGeneratedBy ECO_0000203 NP1233254.RAE3k7yYND35Hf8Y8YzhFUMt8Aks3Xbc2sDD0Tu02wrHc130_provenance.